John T. French, MD

Northwest Georgia Oncology Centers, P.C. Marietta Cancer Center 340 Kennestone Hospital Blvd.
Suite 200
Marietta, GA 30060
Phone: (770) 281-5100
Fax: (678) 581-7100

John T. French, MD joined the cancer care team of  Northwest Georgia Oncology Centers, P.C. in September 2016 upon completion of his fellowship in Medical Oncology and Hematology at the MD Anderson Cancer Center in Houston, TX in June 2016.   He completed his internship and residency at  Vanderbilt University Medical Center in Nashville, TN in June 2013 and received his Doctorate of Medicine from the Medical College of Georgia in May 2010.

He is actively involved in cancer research and clinical trials to provide his patients with the most advanced cancer treatment available in Georgia as an Investigator of the William S. Gibbons Cancer Research Institute.

Dr. French provides patient-centered cancer care at NGOC’s Marietta Cancer Center.

Undergraduate EducationB.S., Cellular Biology, May 2006
University of Georgia
Athens, GA
Medical EducationDoctor of Medicine, May 2010
Medical College of Georgia
Augusta, GA

Postdoctoral TrainingINTERNSHIP
Internal Medicine
Vanderbilt University, Medical Center
Nashville, TN
July 2010 - June 2011

RESIDENCY
Internal Medicine
Vanderbilt University, Medical Center
Nashville, TN
July 2011 – June 2013

FELLOWSHIP
Hematology & Medical Oncology
MD Anderson Cancer Center
Houston, TX
July 2013 - June 2016
Board CertificationAmerican Board of Internal Medicine, Internal Medicine, 2013
American Board of Internal Medicine, Medical Oncology, 2016
American Board of Internal Medicine, Hematology, 2016
Medical LicensureState of Georgia (April 2016)
Professional SocietiesAmerican Society of Clinical Oncology
American Society of Hematology
MD Anderson House Staff Senate
National Cancer Institute, Pending

HonorsAssociation of Pathology Chairs Honor Society, 2008
Dean's Summer Research Fellowship, 2007
Research Internship in Science and Engineering (RISE) Scholarship, 2005
PublicationsK. Raghav, J. French, N. Ueno, L. Xiudong, S. Krishnamruthy, J. Reuben, V. Valero, N. Ibrahim. Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction. Breast Cancer Research and Treatment. Under Review.

C. Barcenas, J. Wells, D. Chong, J. French, S. Looney, T. Samuel. Racial differences in breast cancer survival from the Medical College of Georgia tumor registry 1990-2005. Clinical Breast Cancer. 2010 February; 10(1): 59-63.

G. Bagchi, J. Wu, J. French, J. Kim, NH Moniri, Y Daaka. Androgens transduce the G alphas-medicated activation of protein kinase A in prostate cells. Cancer Research. 2008 May; 68(9): 3225-31.

Abstracts:
John T. French, Kenneth R. Hess, Diane Liu, Kanwal Raghav, Gabriel N. Hortobagyi, Banu Arun, Vicente Valero, Naoto T. Ueno, Richardo H. Alvarez, Wendy W. Woodward, Bisrat G. Debeb, Stacy L. Moulder, Bora Liam, Debu Tripathy, Buhad K. Ibrahim. Development of CNS metastatasis and subsequent survival in patients with inflammatory breast cancer. American Society of Clinical Oncology Annual Meeting, Chicago, IL. J Clin Oncol 33, June 2015 (suppl: abstr 1586).

Pallavi Sharma, Thomas A. Samuel, Jeremy Wells, Elaine Mebel, John T. French, Jennifer A. Crozier, Stephen W. Looney. Overall Survival Effect of Lower Chemotherapy Dosing in Extremely Obese (BMI≥35) Breast Cancer Patients Based on Adjusted BSA. Poster (Board 15 D). American Society of Clinical Oncology annual meeting in Chicago, IL. Journal of Clinical Oncology, 29 (Iss 15S), June 2011: Abstra 1047.

Pallavi Sharma, Stephen W. Looney, Jeremy Wells, Elaine Mebel, John T, French, Jennifer A. Crozier, Thomas A. Samuel. Breast cancer patients with WHO class II obesity of greater (BMI≥35) have poorer overall survival after receiving chemotherapy compared to similar patients with lower body mass index.